BofA raised the firm’s price target on Ryan Specialty (RYAN) to $92 from $89 and keeps a Buy rating on the shares. Incorporating Q4 results into the firm’s model, BofA’s forward EPS projections decline from higher expense projections in 2025, but expansion in S&P 500 P/E multiple more than offsets the decline in EPS projections, driving the firm’s raised price target the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $76 from $77 at Keefe Bruyette
- Buy Recommendation for Ryan Specialty Group Amid Strong Financial Performance and Growth Prospects
- Strong Financial Performance and Strategic Investments Propel Ryan Specialty Group to ‘Buy’ Rating
- Ryan Specialty Reports Strong Q4 2024 Growth
- Ryan Specialty reports Q4 adjusted EPS 45c, consensus 45c